Insilico signs US$888 million AI drug-development deal days after Hong Kong IPO

South China Morning Post - Jan 5, 2026

Newly Hong Kong-listed biotech firm Insilico Medicine is expected to receive up to US$888 million from a French drug maker under a partnership using Insilico’s proprietary artificial intelligence platform to discover and develop novel cancer drugs. The deal comes just days after the US company’s shares debuted following its initial public offering (IPO), which raised HK$2.28 billion (US$293 million) after the public portion was oversubscribed 1,427 times. The multi-year partnership with Servier,...

Read full article
More News

About Us

Daily World Web took the initiative to utilize the development in cloud and AI technology to create a free, instantaneous and borderless flow of news, the way it should be.

Copyright © 2015 - 2026 Daily World Web. All Rights Reserved.